Clinical Trial Update: SB208 for the Treatment of Tinea Pedis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SB208 targeting tinea pedis (athlete's foot) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• SB208

Snippet

Sponsor: Novan, Inc. | Conditions: Tinea Pedis | Phase 2 | Status: COMPLETED